MediWound reported a quarterly loss of $0.23 per share, substantially better than the Zacks Consensus Estimate of a $0.65 loss. The result also improved from a $0.07 loss per share a year ago, indicating a year-over-year earnings deterioration but a clear beat versus expectations. The headline should be modestly supportive for the stock, though the article provides no revenue or guidance details.
MediWound reported a quarterly loss of $0.23 per share, substantially better than the Zacks Consensus Estimate of a $0.65 loss. The result also improved from a $0.07 loss per share a year ago, indicating a year-over-year earnings deterioration but a clear beat versus expectations. The headline should be modestly supportive for the stock, though the article provides no revenue or guidance details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.32
Ticker Sentiment
